000 01302 a2200373 4500
005 20250513165147.0
264 0 _c19990304
008 199903s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(05)76156-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNatarajan, V
245 0 0 _aHIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy.
_h[electronic resource]
260 _bLancet (London, England)
_cJan 1999
300 _a119-20 p.
_bdigital
500 _aPublication Type: Letter; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAnti-HIV Agents
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLeukocytes, Mononuclear
_xvirology
650 0 4 _aMale
650 0 4 _aViral Load
650 0 4 _aVirus Replication
_xdrug effects
700 1 _aBosche, M
700 1 _aMetcalf, J A
700 1 _aWard, D J
700 1 _aLane, H C
700 1 _aKovacs, J A
773 0 _tLancet (London, England)
_gvol. 353
_gno. 9147
_gp. 119-20
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(05)76156-0
_zAvailable from publisher's website
999 _c9985261
_d9985261